-+ 0.00%
-+ 0.00%
-+ 0.00%

SYSTIMMUNE ANNOUNCES SECOND APPROVAL OF IZA-BREN IN CHINA FOR THE TREATMENT OF RECURRENT OR METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Reuters·07/17/2026 12:00:38

Please log in to view news